{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:43:46Z","timestamp":1793774626890,"version":"4.6.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M761196"],"award-info":[{"award-number":["2024M761196"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202001"],"award-info":[{"award-number":["82202001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioorg.2025.109167","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:02:49Z","timestamp":1761696169000},"page":"109167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Design, synthesis, bioactivity evaluation, and molecular modeling of pyridin-2-yl-pyrimidine: Potential Antimicrobial and anti-tuberculosis agents"],"prefix":"10.1016","volume":"166","author":[{"given":"Xue","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshika","family":"Arumuagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanagaraj","family":"Rajalakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuvaraj","family":"Dinakarkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panneerselvam","family":"Theivendren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvaraj","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109167_bb0005","series-title":"ESKAPE Pathogens: Detection, Mechanisms and Treatment Strategies","first-page":"183","article-title":"Biochemical, molecular, and computational techniques for the determination of virulence factors of ESKAPE pathogens","author":"Jena","year":"2024"},{"key":"10.1016\/j.bioorg.2025.109167_bb0010","first-page":"134","article-title":"Novel drug candidates against antibiotic-resistant microorganisms: A review","volume":"27","author":"Lim","year":"2024","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.bioorg.2025.109167_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2317915","article-title":"ESKAPE in China: epidemiology and characteristics of antibiotic resistance","author":"Luo","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.bioorg.2025.109167_bb0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12879-024-09260-w","article-title":"Bacterial etiology and antimicrobial resistance pattern of pediatric bloodstream infections: a 5-year experience in an Iranian referral hospital","volume":"24","author":"Sajedi Moghaddam","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.109167_bb0025","article-title":"Phototherapy-based multifunctional nanoplatform for synergistic therapy against drug resistance bacteria: progress, advances and challenges","author":"Yu","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bioorg.2025.109167_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1374466","article-title":"Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies","volume":"15","author":"Elfadadny","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bioorg.2025.109167_bb0035","series-title":"Protein Kinases: Promising Targets for Anticancer Drug Research","first-page":"75","article-title":"Importance of protein kinase and its inhibitor: a review","author":"Theivendren","year":"2021"},{"key":"10.1016\/j.bioorg.2025.109167_bb0040","author":"Kumar","year":"2024","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.109167_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202302048","article-title":"Synthesis and antibacterial evaluation of novel psoralen derivatives against methicillin-resistant Staphylococcus aureus (MRSA)","author":"Yang","year":"2024","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2025.109167_bb0050","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.3c00346","article-title":"Interactions between gepotidacin and Escherichia coli gyrase and topoisomerase IV: genetic and biochemical evidence for well-balanced dual-targeting","author":"Oviatt","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.109167_bb0055","article-title":"Gyrase and topoisomerase IV: recycling old targets for new antibacterials to combat fluoroquinolone resistance","author":"Collins","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.109167_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/epj.epj_129_23","article-title":"Insights into bioactive microbial natural products and drug discovery","volume":"23","author":"Hamed","year":"2024","journal-title":"Egypt. Pharm. J."},{"key":"10.1016\/j.bioorg.2025.109167_bb0065","article-title":"Synthesis and molecular docking of pyrimidine derivatives as antibacterial agents","volume":"7","author":"Elumalai","year":"2024","journal-title":"Carbon Resour. Convers."},{"key":"10.1016\/j.bioorg.2025.109167_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137965","article-title":"Synthesis and antibacterial activities of novel hybrid molecules based on benzothiazole, benzimidazole, benzoxazole, and pyrimidine derivatives, each connected to N-arylacetamide and benzoate groups","volume":"1307","author":"Elwahy","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109167_bb0075","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1134\/S1068162024020134","article-title":"Synthesis and antimicrobial activity of new dihydropyrazolo [1, 5-a] pyrimidine derivatives","volume":"50","author":"Joshi","year":"2024","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109167_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300656","article-title":"Development and evaluation of 2, 4-disubstituted-5-aryl pyrimidine derivatives as antibacterial agents","author":"Khalifa","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.109167_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136485","article-title":"Synthesis and anti-microbial studies of new series of 1, 2, 3, 4-tetrazole integrated thieno [2, 3-d] pyrimidine derivatives","volume":"1295","author":"Nagaraju","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109167_bb0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2174\/1573407214666181001112601","article-title":"Design, in silico modeling, toxicity study and synthesis of novel substituted semicarbazide derivatives of pyrimidine: an antitubercular agent","volume":"16","author":"Mandhadi","year":"2020","journal-title":"Curr. Bioact. Compd."},{"key":"10.1016\/j.bioorg.2025.109167_bb0095","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.3390\/molecules27123799","article-title":"Aphrodisiac performance of bioactive compounds from Mimosa pudica Linn.: in silico molecular docking and dynamics simulation approach","volume":"27","author":"Palanichamy","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109167_bb0100","first-page":"198","article-title":"Ali Synthesis and structure-activity relationship study of 2-(substituted benzylidene)-7-(4-fluorophenyl)-5-(furan-2-yl)-2H-thiazolo [3, 2-a] pyrimidin-3 (7H)-one derivatives as anticancer agents","volume":"6","author":"Panneerselvam","year":"2012","journal-title":"Drug Dis. Therap."},{"key":"10.1016\/j.bioorg.2025.109167_bb0105","first-page":"487","article-title":"Graph theoretical network analysis, in silico exploration, and validation of bioactive compounds from Cynodon dactylon as potential neuroprotective agents against \u03b1-synuclein","volume":"12","author":"Rajeshkumar","year":"2022","journal-title":"BioImpacts: BI"},{"key":"10.1016\/j.bioorg.2025.109167_bb0110","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ddr.21511","article-title":"Graph theoretical analysis, in silico modeling, prediction of toxicity, metabolism and synthesis of novel 2-(methyl\/phenyl)-3-(4-(5-substituted-1, 3, 4-oxadiazol-2-yl) phenyl) quinazolin-4 (3H)-ones as NMDA receptor inhibitor","volume":"80","author":"Saravanan","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2025.109167_bb0115","first-page":"117","article-title":"Synthesis and antitubercular activity of some novel 2, 5-dimethyl pyrrolyl benzohydrazide derivatives, Indian","volume":"27","author":"Dixit","year":"2017","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2025.109167_bb0120","series-title":"Design, Optimization, Synthesis and AntiTB Screening of Benzimidazole Derivatives, Anti-Infective Agents","first-page":"24","volume":"18","author":"Panneerselvam","year":"2020"},{"key":"10.1016\/j.bioorg.2025.109167_bb0125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5582\/ddt.2016.01048","article-title":"Design, docking analysis, identification, and synthesis of novel 3-(((substituted phenyl) amino) methyl)-2-methylquinazolin-4 (3H)-one compounds to fight tuberculosis","volume":"10","author":"Panneerselvam","year":"2016","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.bioorg.2025.109167_bb0130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/2212796811666170615131140","article-title":"Design, network analysis, in silico modeling and synthesis of biologically active thiazolo quinazoline scaffolds as anti-tubercular agent","volume":"11","author":"Theivendren","year":"2017","journal-title":"Curr. Chem. Biol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T01:10:52Z","timestamp":1766106652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825010478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":26,"alternative-id":["S0045206825010478"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109167","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, bioactivity evaluation, and molecular modeling of pyridin-2-yl-pyrimidine: Potential Antimicrobial and anti-tuberculosis agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109167"}}